Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vinblastine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01476410
What this trial is testing

Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+4 more
Northwestern University 49
Testing effectiveness (Phase 2)Study completedNCT00003019
What this trial is testing

Vinblastine and Methotrexate in Treating Children With Desmoid Tumors

Who this might be right for
Desmoid Tumor
Children's Oncology Group 28
Large-scale testing (Phase 3)Study completedNCT00002882
What this trial is testing

Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma

Who this might be right for
MelanomaSkin Cancer
M.D. Anderson Cancer Center 140
Testing effectiveness (Phase 2)UnknownNCT04781725
What this trial is testing

INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast Cancer

Who this might be right for
Breast Cancer
Ottawa Hospital Research Institute 90
Large-scale testing (Phase 3)Study completedNCT00003027
What this trial is testing

Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Eastern Cooperative Oncology Group 482
Testing effectiveness (Phase 2)Study completedNCT00061893
What this trial is testing

Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors

Who this might be right for
Sarcoma
Children's Oncology Group 38
Testing effectiveness (Phase 2)Looking for participantsNCT06377566
What this trial is testing

BV-AVD in People With Bulky Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center 71
Testing effectiveness (Phase 2)Active Not RecruitingNCT02758717
What this trial is testing

Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma

Who this might be right for
Ann Arbor Stage IB Hodgkin LymphomaAnn Arbor Stage II Hodgkin LymphomaAnn Arbor Stage IIA Hodgkin Lymphoma+8 more
Academic and Community Cancer Research United 46
Early research (Phase 1)Study completedNCT00352495
What this trial is testing

Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma

Who this might be right for
Brain and Central Nervous System TumorsNeurofibromatosis Type 1
Children's Oncology Group 26
Large-scale testing (Phase 3)Study completedNCT00006237
What this trial is testing

S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma

Who this might be right for
Melanoma (Skin)
SWOG Cancer Research Network 432
Testing effectiveness (Phase 2)Study completedNCT01022996
What this trial is testing

Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment.

Who this might be right for
Hodgkin Lymphoma
Novartis Pharmaceuticals 57
Early research (Phase 1)Study completedNCT01056679
What this trial is testing

Adriamycin, Vinblastine, DTIC and Revlimid in Elderly Hodgkin Lymphoma Patients

Who this might be right for
Hodgkin Lymphoma
University of Cologne 30
Large-scale testing (Phase 3)Looking for participantsNCT02670707
What this trial is testing

Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)

Who this might be right for
Langerhans Cell Histiocytosis
Baylor College of Medicine 124
Testing effectiveness (Phase 2)Looking for participantsNCT05180825
What this trial is testing

Pediatric Low Grade Glioma - MEKinhibitor TRIal vs Chemotherapy

Who this might be right for
Grade 1 GliomaMixed Glio-neuronal TumorsPleomorphic Xanthoastrocytoma
University Hospital, Strasbourg, France 134
Testing effectiveness (Phase 2)Study completedNCT02414568
What this trial is testing

Bendamustine Study in Classical Hodgkin Lymphoma Patients Over 60 Treated by Prednisone, Vinblastine and Doxorubicin

Who this might be right for
Classical Hodgkin Lymphoma
The Lymphoma Academic Research Organisation 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT03233347
What this trial is testing

Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma

Who this might be right for
Ann Arbor Stage I Hodgkin LymphomaAnn Arbor Stage IA Hodgkin LymphomaAnn Arbor Stage IB Hodgkin Lymphoma+4 more
Academic and Community Cancer Research United 83
Testing effectiveness (Phase 2)WithdrawnNCT01639521
What this trial is testing

Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer

Who this might be right for
Anterior Urethral CancerLocalized Transitional Cell Cancer of the Renal Pelvis and UreterPosterior Urethral Cancer+7 more
University of Southern California